GGrantIndex
Sort

17,828 grants matching crispr

Biology and novel therapy of AML expressing somatic or germline mutant RUNX1

$496,911
Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Molecular Vector and Conditional ES Cell Clone Collection Validation and Maintenance Plan by theMMRRC at UC Davis

$496,901
Kc Kent Lloyd · University Of California At Davis · U42 · FY2025 · OD

Novel DNA damage response therapeutics targeting replication protein A

$496,895
John J Turchi · Indiana University Indianapolis · R01 · FY2022 · CA

Potency and contribution of zebrafish progenitors during innate spinal cord repair

$496,776
Mayssa H. Mokalled · Washington University · R01 · FY2025 · NS

Identification of gene regulatory networks that control proliferative and neurogenic competence in mammalian Müller glia

$496,508
Seth Blackshaw · Johns Hopkins University · R01 · FY2021 · EY

Identification of gene regulatory networks that control proliferative and neurogenic competence in mammalian Müller glia

$496,507
Seth Blackshaw · Johns Hopkins University · R01 · FY2022 · EY

Epigenetics of inner ear neurosensory cell development

$496,506
Donna M Martin · University Of Michigan At Ann Arbor · R01 · FY2020 · DC

Therapeutics for the chorioretina

$496,438
Sofia P Becerra · National Eye Institute · ZIA · FY2021 · EY

3D Culture Models of Partial-EMT and Its Regulation in Oral Cavity Squamous Cell Carcinoma

$496,368
Anuraag Suhrid Parikh · Columbia University Health Sciences · K08 · FY2025 · DE

Role of LGR+ connective tissue progenitors in TMJ development

$496,320
Gage D Crump · University Of Southern California · R01 · FY2025 · DE

Role of LGR+ connective tissue progenitors in TMJ development

$496,320
Gage D Crump · University Of Southern California · R01 · FY2024 · DE

Chromatin Organization Regulates Osteogenesis

$496,258
Gary S. Stein · University Of Vermont & St Agric College · R01 · FY2024 · DE

Receptor Mediated T and B Cell Activation

$496,200
Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Developing New Treatment Strategies for Neuroendocrine Prostate Cancer

$496,079
Joshi James Alumkal · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

A cross-species approach to hypersomnia genetics informed by human GWAS

$495,816
Alessandra Chesi · University Of Pennsylvania · R01 · FY2024 · NS

Unraveling the 10q AMD Risk Locus

$495,753
Edwin M Stone · University Of Iowa · R01 · FY2016 · EY

Unraveling the 10q AMD Risk Locus

$495,753
Edwin M Stone · University Of Iowa · R01 · FY2018 · EY

Unraveling the 10q AMD Risk Locus

$495,753
Edwin M Stone · University Of Iowa · R01 · FY2019 · EY

Unraveling the 10q AMD Risk Locus

$495,753
Edwin M Stone · University Of Iowa · R01 · FY2017 · EY

Deciphering pathogenesis and therapeutic vulnerabilities in germline RUNX1 mutated AML

$495,715
Wenbin Xiao · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA

Deregulation of long noncoding RNAs in cancer

$495,683
Nadya M Dimitrova · Yale University · R01 · FY2023 · CA

CRISPR-enabled Multimodal Electrochemical Devices for Ultrasensitive, Preamplification-free Nucleic Acid Testing

$495,516
Seyedehaida Ebrahimi · Pennsylvania State Univ University Park · · FY2025 · ENG

Role of FABP5 in COPD Exacerbations

$495,444
Fabienne Gally · National Jewish Health · R01 · FY2022 · HL

Glucocorticoid receptor phosphorylation in endocrine adaptation to stress

$495,420
Michael J Garabedian · New York University School Of Medicine · R56 · FY2020 · MH

Stem cell regulation during development and whole-body regeneration

$495,350
Mansi Srivastava · Harvard University · R35 · FY2024 · GM